$SIRO (Sirona Dental Systems Inc.)

$SIRO {{ '2016-02-25T17:01:10+0000' | timeago}} • Announcement

$XRAY and $SIRO announced that the proposed merger of equals between the two companies has cleared regulatory review. Following similar approvals in the U.S. and Ukraine, both European Commission and Russia's Federal Antimonopoly Service have announced approval of proposed merger. The companies now see deal to close on or about Feb. 29.

$ABT {{ '2017-07-20T19:55:45+0000' | timeago}} • Webcast

For 3Q17, $ABT expects adjusted EPS of $0.64-0.66, with operational sales growth expected in the mid-single digits. At current exchange rates, the company expects operational sales growth to have a negative YoY impact of around 0.5%.

$ABT {{ '2017-07-20T19:45:56+0000' | timeago}} • Webcast

$ABT said that on a comparable operational basis, 3Q17 Established Pharmaceuticals sales growth is expected in the high double-digit, while in Nutrition, sales growth is expected in low single-digit. In Diagnostics, $ABT expects sales to increase mid-to-high single digits and in Medical Devices, sales is expected to increase double-digits.

$ABT {{ '2017-07-20T17:49:19+0000' | timeago}} • Announcement

$ABT raised its full year profit forecast backed by the intention of closing the Alere acquisition in 2017. The company raised its FY17 adjusted earnings from continuing operations guidance by $0.03 to a range of $2.43-2.53 per share. Reported EPS forecast was also raised from the range of $0.92-1.02 to $1.03-1.13, reflecting double-digit growth.

$ABT {{ '2017-07-20T17:36:53+0000' | timeago}} • Announcement

Declining operating earnings and rising costs and expenses hit $ABT 2Q17 earnings as much as 54%. Earnings plunged to $283MM or $0.15 from $615MM or $0.40 per share a year earlier. Sales, however, surged 24.4% on St. Jude Medical acquisition. On an adjusted basis, $ABT reported EPS above its previous guidance range at $0.62 per share.

$INCY {{ '2017-07-20T13:24:37+0000' | timeago}} • Announcement

$INCY said first patient has been treated in Phase 3 trial of itacitinib for the first-line treatment of patients with acute graft-versus-host disease (GVHD). GVHD is a condition that might occur after an allogeneic transplant, whereby the donated bone marrow or peripheral blood stem cells view the recipient’s body as foreign and attack the body.

$ABT {{ '2017-07-20T12:52:57+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q2 2017 Highlights

$AKRX {{ '2017-07-19T21:41:28+0000' | timeago}} • Announcement

Specialty generic pharmaceutical company $AKRX said that its shareholders have voted to approve the merger for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA. The companies expect the acquisition to close by early 2018.

$NEM {{ '2017-07-19T20:55:03+0000' | timeago}} • Announcement

$NEM elected Sheri Hickok and Molly Zhang to its BoD. Hickok is currently General Manager, Global Product Development, Onshore Wind at $GE's Renewable Energy. Zhang currently serves as a director of Cooper Standard Automotive and XG Science as a supervisory board member at GEA Group in Germany.

$AGN {{ '2017-07-19T15:54:53+0000' | timeago}} • Announcement

$AGN appointed Joseph Boccuzi to its BoD, effective immediately. Boccuzi recently retired as a Partner in the Global Life Sciences, Board and Chief Executive Officer Practices at Spencer Stuart, following 24 years of service with the global executive search and leadership consulting firm.

$GS {{ '2017-07-19T11:22:37+0000' | timeago}} • Webcast

$GS advised a number of important transactions that were announced during 2Q17, including $BCR's $24Bil sale to $BDX. $AMZN's $13.7Bil acquisition of $WFM, and $DFT's $7.6Bil merger with $DLR.

$MSFT {{ '2017-07-18T12:18:43+0000' | timeago}} • Announcement

Kate Johnson to join $MSFT as President and Corporate VP of Microsoft US on Sept 8, 2017. Johnson currently serves as Chief Commercial Officer of GE Digital, a unit of $GE.

$ABT {{ '2017-07-17T12:36:21+0000' | timeago}} • Announcement

$ABT is commencing a tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share of Preferred Stock. The offer will expire at 11:59 pm, NYC time, on Aug 11, 2017. There is no financing condition to the offer.

$XRAY {{ '2017-07-14T15:40:42+0000' | timeago}} • Announcement

Dental solutions provider $XRAY declared a quarterly cash dividend of $0.0875 per common share. The corresponding annual rate has increased 12.9% to $0.35 per share from the prior annual rate of $0.31 per share. The dividend is payable on April 13, 2017 to shareholders of record on March 31, 2017.

$AMGN {{ '2017-07-13T12:24:26+0000' | timeago}} • Announcement

$AMGN and $AGN announced they will discuss data supporting the ABP 215 Biologics License Application (BLA) with FDA's Oncologic Drugs Advisory Committee. ABP 215 is a biosimilar candidate to Avastin (bevacizumab) and is the first bevacizumab biosimilar candidate to be considered by the FDA.

$ABT {{ '2017-07-13T12:23:21+0000' | timeago}} • Announcement

$ABT and Bigfoot Biomedical agreed to develop and commercialize diabetes management systems, integrating $ABT's FreeStyle Libre glucose sensing technology with Bigfoot's insulin delivery solutions in the United States. $ABT will provide Bigfoot with the next generation of its FreeStyle Libre glucose sensing technology.

$GE {{ '2017-07-11T10:55:50+0000' | timeago}} • Announcement

$GE said its subsidiary GE Healthcare is expanding its U.S. healthcare consulting business with the acquisition of Novia Strategies, a healthcare consulting firm, for undisclosed terms. Novia Strategies will become part of GE Healthcare Camden Group. Novia Solutions was not included as a part of this transaction.

$AGN {{ '2017-07-10T16:14:16+0000' | timeago}} • Announcement

$AGN announced additional results of a prespecified prospective pooled subgroup analysis from the two Phase 3 studies, which evaluated the efficacy and safety of Viberzi to treat the symptoms associated with irritable bowel syndrome with diarrhea, abdominal pain and diarrhea.

$ATI {{ '2017-07-05T15:28:15+0000' | timeago}} • Announcement

Specialty materials manufacturer $ATI has entered into joint venture with $GE company GE Aviation for developing technology to produce a meltless titanium alloy powder. As per the deal, the companies will set up a new R&D pilot production facility. The alloy will be used in additive manufacturing applications, including 3D printing.

$GE {{ '2017-07-03T17:17:55+0000' | timeago}} • Announcement

$GE closed the combination of GE's oil and gas business with Baker Hughes, a GE company. Under the deal, Baker Hughes was converted to a partnership and GE contributed its Oil & Gas business into that partnership. Meanwhile, $7.4Bil was contributed by GE to the partnership, which will be used to fund the cash dividend to Baker Hughes shareholders.

$BHI {{ '2017-07-03T16:00:37+0000' | timeago}} • Announcement

Oilfield solutions provider $BHI said it has completed the transaction combining the company with the oil and gas business of $GE. Baker Hughes shares will begin trading on the New York Stock Exchange under the symbol BHGE on July 5, 2017. Meanwhile, the existing symbol, BHI, will be delisted from the stock exchange on July 3, 2017.

Recent Transcripts

ANGO (AngioDynamics Inc.)
Tuesday, July 18 2017 - 12:00pm
MCK (McKesson Corporation)
Thursday, May 18 2017 - 9:00pm
FARO (FARO Technologies Inc.)
Wednesday, May 10 2017 - 12:30pm
ACAD (ACADIA Pharmaceuticals Inc.)
Tuesday, May 9 2017 - 9:00pm
AGN (Allergan plc)
Tuesday, May 9 2017 - 12:30pm
ATRS (Antares Pharma Inc.)
Tuesday, May 9 2017 - 12:30pm
XRAY (DENTSPLY International Inc.)
Tuesday, May 9 2017 - 12:30pm
INCY (Incyte Corporation)
Thursday, May 4 2017 - 2:00pm
TFX (Teleflex Incorporated)
Thursday, May 4 2017 - 12:00pm
OSUR (OraSure Technologies, Inc.)
Wednesday, May 3 2017 - 9:00pm
AMRN (Amarin Corporation plc)
Wednesday, May 3 2017 - 12:00pm
KTWO (K2M Group Holdings, Inc.)
Tuesday, May 2 2017 - 9:00pm
ALGN (Align Technology Inc.)
Thursday, April 27 2017 - 8:30pm
MMM (3M Company)
Tuesday, April 25 2017 - 1:00pm
PHG (Koninklijke Philips N.V)
Monday, April 24 2017 - 8:00am
GE (General Electric Company)
Friday, April 21 2017 - 12:30pm
NURO (NeuroMetrix Inc.)
Thursday, April 20 2017 - 12:00pm
ABT (Abbott Laboratories)
Wednesday, April 19 2017 - 1:00pm
ANGO (AngioDynamics Inc.)
Thursday, March 30 2017 - 12:00pm
ATRS (Antares Pharma Inc.)
Tuesday, March 14 2017 - 12:30pm

AlphaGraphics you may like